Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Application - Canada Graduate Scholarships-Master’s Program
FY 2017-18
Summary
RNA is best known as the intermediary molecule between the body's blueprint, genes written in DNA; and its wood and bricks, protein. However, non-coding RNAs (ncRNA) are a diverse group of RNA molecules capable of functions beyond serving as a stepping stone in protein production. This class of molecules includes long non-coding RNAs (lncRNAs), which play an important role in human diseases, including cancer. One way that lncRNAs work is by binding a gene and recruiting proteins that can modify the gene in some way, such as by adding chemical tags directly to the DNA or other associated proteins. Depending on the gene affected, changes in lncRNA activity can result in genetic modifications that contribute to cancer development and progression. Given that there are tens of thousands of unique lncRNAs that vary significantly in abundance depending on tissue type or disease state, it can be difficult to determine the precise function of a given lncRNA. A more effective approach is where my proposed research comes in, as I intend to apply powerful Next Generation Sequencing technologies for the genome-wide profiling of which lncRNAs are abnormally bound in cancer, and to which genes. With a large enough number of cancerous and healthy cells sequenced, recurring cancer subtype-specific differences in lncRNA binding may be discovered. I am hypothesizing that lncRNAs will be bound more frequently to genes associated with cancer development than they are in the healthy cells cancer arises from. Combining this profile with information about what other lncRNA mediated modifications have occurred may reveal how a tumour arose and progressed, as well as what kind of treatment would be most effective, and may even reveal novel targets for therapies.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
386420
Name
Yellan Isaac M
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Application - Canada Graduate Scholarships-Master’s Program
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Cancer; Epigenetics; Epigenomics; Genetics; Genomics; Long Non-Coding Rna; Non-Coding Rna; Regulation; Sequencing
Abstract
RNA is best known as the intermediary molecule between the body's blueprint, genes written in DNA; and its wood and bricks, protein. However, non-coding RNAs (ncRNA) are a diverse group of RNA molecules capable of functions beyond serving as a stepping stone in protein production. This class of molecules includes long non-coding RNAs (lncRNAs), which play an important role in human diseases, including cancer. One way that lncRNAs work is by binding a gene and recruiting proteins that can modify the gene in some way, such as by adding chemical tags directly to the DNA or other associated proteins. Depending on the gene affected, changes in lncRNA activity can result in genetic modifications that contribute to cancer development and progression. Given that there are tens of thousands of unique lncRNAs that vary significantly in abundance depending on tissue type or disease state, it can be difficult to determine the precise function of a given lncRNA. A more effective approach is where my proposed research comes in, as I intend to apply powerful Next Generation Sequencing technologies for the genome-wide profiling of which lncRNAs are abnormally bound in cancer, and to which genes. With a large enough number of cancerous and healthy cells sequenced, recurring cancer subtype-specific differences in lncRNA binding may be discovered. I am hypothesizing that lncRNAs will be bound more frequently to genes associated with cancer development than they are in the healthy cells cancer arises from. Combining this profile with information about what other lncRNA mediated modifications have occurred may reveal how a tumour arose and progressed, as well as what kind of treatment would be most effective, and may even reveal novel targets for therapies.
Competitiondate
201712
Approvedterm2
1 yr 0 mth
Pinamesdelim
Yellan, Isaac M
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~